Jefferies sees 34% upside in Dormakaba on margin expansion, U.S. growth
Jefferies upgraded Dormakaba (SIX: DOKA) to 'buy' with a CHF 82 price target, citing margin expansion and U.S. growth. The target implies 34% upside from the Sept. 25 close. The broker expects adjusted EBITDA margins to rise to 18% by fiscal 2028/29, above consensus. Dormakaba reported a record EBITDA margin of 16.1% in fiscal 2025/26, driven by cost savings and pricing gains. The company's restructuring program delivered CHF 235 million in savings, exceeding its target.
How this was made
The 30-second read
Why it matters
The upgrade could trigger buying interest and push the share price toward the new target.
Market read
Analyst upgrade with a specific price target offers a clear trading signal for Dormakaba.
What to watch
Potential dilution from the ownership‑structure simplification and upcoming AGM vote.
Background
Jefferies' research note provides new valuation and margin guidance for Dormakaba.
Market effects
Positive outlook for the access‑solutions sector as margin expansion may set a benchmark.
U.S. growth expectations could lift other Swiss exporters with North‑America exposure.
Limited to investors tracking European industrial stocks and AI‑related hardware demand.
Counterpoint
Execution risk remains high; U.S. growth may lag, potentially limiting upside.
Key entities
- companyDormakaba Holding AG
Swiss access‑solutions maker receiving a buy upgrade.
- research_firmJefferies
Analyst firm issuing the upgrade and price target.
